Literature DB >> 3021632

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.

B E Ivins, S L Welkos.   

Abstract

The gene encoding the protective antigen (PA) moiety of the tripartite exotoxin of Bacillus anthracis was cloned from the recombinant plasmid pSE36 into Bacillus subtilis 1S53 by using the plasmid vector pUB110. Two clones, designated PA1 and PA2, were identified which produced PA in liquid cultures at levels of 20.5 to 41.9 micrograms/ml. This PA was identical to B. anthracis Sterne PA with respect to migration on sodium dodecyl sulfate-polyacrylamide gels and to Western blot antigenic reactivity. Addition of lethal factor or edema factor to PA1 and PA2 supernatants generated biologically active anthrax lethal toxin or edema-producing toxin, respectively. The recombinant plasmid in PA1 (pPA101) was 7.8 kilobases, whereas the PA2 strain plasmid (pPA102) was 6.1 kilobases. Both plasmids had deletions extending into the insert sequence but not into the DNA encoding the PA protein. Immunization with the live recombinant strains protected guinea pigs from lethal challenge with virulent B. anthracis spores, and the immunization partially or completely protected rats from intravenous challenge with anthrax lethal toxin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021632      PMCID: PMC260194          DOI: 10.1128/iai.54.2.537-542.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  General method for the isolation of plasmid deoxyribonucleic acid.

Authors:  P Guerry; D J LeBlanc; S Falkow
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

3.  Restriction maps of plasmids pUB110 and pBD9.

Authors:  A Jalanko; I Palva
Journal:  Gene       Date:  1981-09       Impact factor: 3.688

4.  Characterization of proteinases excreted by Bacillus subtilis Marburg strain during sporulation.

Authors:  J Millet
Journal:  J Appl Bacteriol       Date:  1970-03

5.  High frequency transformation of Bacillus subtilis protoplasts by plasmid DNA.

Authors:  S Chang; S N Cohen
Journal:  Mol Gen Genet       Date:  1979-01-05

6.  Characterization of Staphylococcus aureus plasmids introduced by transformation into Bacillus subtilis.

Authors:  T J Gryczan; S Contente; D Dubnau
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

7.  Cloning of the Bacillus subtilis sulfanilamide resistance gene in Bacillus subtilis.

Authors:  K O McDonald; W F Burke
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

8.  Construction and properties of chimeric plasmids in Bacillus subtilis.

Authors:  T J Gryczan; D Dubnau
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Elaboration of Bacillus anthracis antigens in a new, defined culture medium.

Authors:  J D Ristroph; B E Ivins
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS.

Authors:  B W HAINES; F KLEIN; R E LINCOLN
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

View more
  29 in total

1.  Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity.

Authors:  Y Lu; R Friedman; N Kushner; A Doling; L Thomas; N Touzjian; M Starnbach; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Transposon Tn916 mutagenesis in Bacillus anthracis.

Authors:  B E Ivins; S L Welkos; G B Knudson; D J Leblanc
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.

Authors:  Orit Gat; Haim Grosfeld; Naomi Ariel; Itzhak Inbar; Galia Zaide; Yehoshua Broder; Anat Zvi; Theodor Chitlaru; Zeev Altboum; Dana Stein; Sara Cohen; Avigdor Shafferman
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Genetic screening for bacterial mutants in liquid growth media by fluorescence-activated cell sorting.

Authors:  Basel H Abuaita; Jeffrey H Withey
Journal:  J Microbiol Methods       Date:  2010-11-19       Impact factor: 2.363

5.  Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.

Authors:  B E Ivins; S L Welkos; G B Knudson; S F Little
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

6.  Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

Authors:  L C Iacono-Connors; C S Schmaljohn; J M Dalrymple
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide.

Authors:  J W Ezzell; T G Abshire; S F Little; B C Lidgerding; C Brown
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 8.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

9.  Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters.

Authors:  T M Koehler; Z Dai; M Kaufman-Yarbray
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

10.  Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.

Authors:  L C Iacono-Connors; S L Welkos; B E Ivins; J M Dalrymple
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.